IGC Pharma (IGC) Amortization - Intangibles (2010 - 2011)

IGC Pharma (IGC) reported Amortization - Intangibles of -$164632.0 for Q1 2011, down 193.26% quarter-over-quarter from $176526.0 in Q3 2010.

IGC Pharma (IGC) Amortization - Intangibles (2010 - 2011) Analysis & Trends

IGC Pharma (IGC) has 2 years of Amortization - Intangibles data on file, last reported at -$164632.0 in Q1 2011.

Amortization - Intangibles for Q1 2011 came in at -$164632.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2011 was $191804.0 (changed N/A YoY), and the FY2011 annual result was $191804.0, changed N/A from the prior year.
Amortization - Intangibles eased to -$164632.0 in Q1 2011 per IGC's latest filing, from $176526.0 in the prior quarter.
Over five years, Amortization - Intangibles peaked at $179910.0 in Q2 2010 and troughed at -$164632.0 in Q1 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	788,338.31 Bn	788,338.28 Bn	-
2	Belite Bio	56,560.00 Bn	56,560.00 Bn	-
3	Quantum Biopharma	17,329.30 Bn	17,329.30 Bn	-
4	Legend Biotech	3,341.00 Bn	3,340.71 Bn	242.10 Mn
5	Akari Therapeutics	1,727.91 Bn	1,727.91 Bn	-
6	Evaxion A	1,536.68 Bn	1,536.67 Bn	-
7	Psyence Biomedical	238.34 Bn	238.33 Bn	-
8	Vertex Pharmaceuticals	113.42 Bn	106.17 Bn	2.59 Bn
9	Abivax	95.45 Bn	95.45 Bn	-
10	IGC Pharma	28.11 Mn	27.85 Mn	-

Download Data